Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ahz-zinc
2. Beta-alanyl-l-histidinato Zinc
3. Polaprezinc
4. Z 103
5. Z-103
6. Zinc Carnosine
7. Zinc L-carnosine Complex
8. Zinc N-(3-aminopropionyl)histidine
1. Polaprezinc
2. 107667-60-7
3. Polaprezinc [inn]
4. Beta-alanyl-l-histidinato Zinc
5. Z 103
6. Carnosine Zinc
7. (s)-2-(3-aminopropanamido)-3-(1h-imidazol-5-yl)propanoic Acid Zinc Complex
8. 0wa1b15a1z
9. Promac (antiulcer Agent)
10. Unii-0wa1b15a1z
11. Ccris 3974
12. Hy-b0729
13. N(alpha)-(3-aminopropionyl)histidinato(2-)n1,n2,o(alpha))-zinc
14. Cs-7571
15. Zinc, (beta-alanyl-kappan-l-histidinato(2-)-kappan,kappao)-
16. Zinc, (n-beta-alanyl-l-histidinato(2-)-n,n(sup N),o(sup Alpha))-
17. (s)-2-(3-aminopropanamido)-3-(1h-imidazol-5-yl)propanoicacidzinccomplex
18. Zinc, (n-beta-alanyl-l-histidinato(2-)-n,n(n),n3,o(alpha))-, (t-4)-
19. Catena-poly(zinc-mu-(beta-alanyl-l-histidinato(2(-))-n,n(sup N),o:n(sup Tau)))
20. Catena-poly(zinc-mu-(beta-alanyl-l-histidinato(2-)-n,n(sup N),o:n(sup Tau)))
Molecular Weight | 288.6 g/mol |
---|---|
Molecular Formula | C9H11N4O3Zn- |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 287.012257 g/mol |
Monoisotopic Mass | 287.012257 g/mol |
Topological Polar Surface Area | 87.9 Ų |
Heavy Atom Count | 17 |
Formal Charge | -1 |
Complexity | 265 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?